Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems

Volume: 2 Number: 1 March 20, 2010
EN

Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems

Abstract

In 2005, doripenem, the newest carbapenem on the market, was developed by a pharmaceutical company in Japan, and it was recently approved by the United States (US) Federal Drug Administration (FDA) to be used in the adult population. Doripenem is a broad spectrum antimicrobial agent that can be used in many different infections ranging from pneumonia to abdominal infections. Even though doripenem has shown to be safe and efficacious in adults, it lacks pharmacokinetic and safety information in the pediatric population. However, by looking at the pediatric pharmacokinetic data of other carbapenems and a recent multicenter study of doripenem in patients between the age of 3 months and 18 years of age, clinicians can gain a better understanding of how to dose this antimicrobial agent in infants, children, and adolescents.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Patrick Grove This is me

Publication Date

March 20, 2010

Submission Date

February 23, 2010

Acceptance Date

-

Published in Issue

Year 1970 Volume: 2 Number: 1

APA
Grove, P., & So, T.-Y. (2010). Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems. Journal of Pediatric Sciences, 2(1). https://doi.org/10.17334/jps.61317
AMA
1.Grove P, So TY. Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems. Journal of Pediatric Sciences. 2010;2(1). doi:10.17334/jps.61317
Chicago
Grove, Patrick, and Tsz-Yin So. 2010. “Doripenem Use in Pediatrics A€“ Learning from Pharmacokinetic Data of Other Carbapenems”. Journal of Pediatric Sciences 2 (1). https://doi.org/10.17334/jps.61317.
EndNote
Grove P, So T-Y (January 1, 2010) Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems. Journal of Pediatric Sciences 2 1
IEEE
[1]P. Grove and T.-Y. So, “Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems”, Journal of Pediatric Sciences, vol. 2, no. 1, Jan. 2010, doi: 10.17334/jps.61317.
ISNAD
Grove, Patrick - So, Tsz-Yin. “Doripenem Use in Pediatrics A€“ Learning from Pharmacokinetic Data of Other Carbapenems”. Journal of Pediatric Sciences 2/1 (January 1, 2010). https://doi.org/10.17334/jps.61317.
JAMA
1.Grove P, So T-Y. Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems. Journal of Pediatric Sciences. 2010;2. doi:10.17334/jps.61317.
MLA
Grove, Patrick, and Tsz-Yin So. “Doripenem Use in Pediatrics A€“ Learning from Pharmacokinetic Data of Other Carbapenems”. Journal of Pediatric Sciences, vol. 2, no. 1, Jan. 2010, doi:10.17334/jps.61317.
Vancouver
1.Patrick Grove, Tsz-Yin So. Doripenem Use in Pediatrics a€“ Learning from Pharmacokinetic Data of Other Carbapenems. Journal of Pediatric Sciences. 2010 Jan. 1;2(1). doi:10.17334/jps.61317